Dr. Fahmi Aldhaheri

تشرفت اليوم بإجراء لقاء في برنامج #طبابة إذاعة @AlifAlifFM عن أمراض الكلى وطرق الوقاية رابط الحلقة youtu.be/c3ovvvAWtFU #فضفضة_طبيب #صحة_الكلى @Jeddah_Doctors @DSFHospital

Join us for our next @GlomCon Arabia seminar on Friday, March 27, 2026, to learn about Cryoglobulinemia from @zainabo87 To join the meeting, hit the "Join" button on Zoom and enter the details below: Meeting ID: 884 4208 1901 Passcode: 100499

مستشفى د. سليمان #فقيه بجدة بين أفضل 250 مستشفى في العالم وفق تصنيف Newsweek، كأول مستشفى خاص بالمملكة يحقق هذا الإنجاز، متصدرًا مستشفيات القطاع الخاص، وثاني أفضل مستشفى على مستوى القطاعين الخاص والحكومي السعوديين، وضمن أفضل 3 مستشفيات عربيًا، وفي المركز 206 عالميًا. لزيارة موقعنا: bit.ly/4uyIzZY #لما_هو_أهم

In adults with type 1 diabetes and chronic kidney disease with albuminuria, the decrease in the urinary albumin-to-creatinine ratio was significantly greater with finerenone than with placebo. Full phase 3 FINE-ONE trial results and Research Summary: nejm.org/doi/full/10.10…

للعام الخامس على التوالي، يتصدر مستشفى الدكتور سليمان فقيه بجدة قائمة أفضل مستشفى خاص في المملكة، ويحقق المرتبة الثانية على مستوى جميع المستشفيات، وفق تصنيف نيوزويك العالمي. إنجاز يعكس رحلة مستمرة من التميز… وثقة نضعها دائمًا في مقدمة مسؤولياتنا. لمعرفة المزيد: bit.ly/jeddah-fakeeh-…

I want to share another great summary by future nephrologist Carla Valencia. Here is a great summary of the latest dietary guidelines that can easily be shared with your patients, family and friends. #NANI #KidneyStrong #CKD #nephrology kidneystronger.com/post/eat-for-y…

📅 Starting Friday, Jan 9, 2026, GlomCon Arabia launches a 🆓 monthly seminar series featuring established experts and emerging leaders in glomerulonephritis, designed for nephrologists, internists, and pathologists across the Arab region 🌍, tailored to the clinical challenges, priorities, and time zones of Arabic-speaking clinicians 🩺. 2/

نفخر في مركز الكلى بمستشفى الأمير متعب بن عبدالعزيز بتحقيق المركز الأول بين المراكز المتخصصة في منطقة الجوف خلال الربع الثاني والثالث والرابع 🥇 إنجاز يعكس عملاً مؤسسياً متكاملاً وجودة عالية في الأداء، بفضل الله ثم بجهود فريق طبي وتمريضي وفني وهندسي متميز. شكرًا لكل من كان جزءًا من هذا النجاح… ومستمرون نحو الأفضل 💙 #تجمع_الجوف_الصحي

We are pleased to share the publication of the KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD), a comprehensive update to the 2012 guideline. Read the guideline in @Kidney_Int: kdigo.co/KDIGO-Anemia-i… Visit the KDIGO Anemia in CKD Guideline website to download the guideline, executive summary, and news release: kdigo.org/guidelines/ane… Co-chaired by Dr. Jodie Babitt (US) and Dr. Marcello Tonelli (CA), the guideline provides evidence-based recommendations for diagnosing and managing anemia across the CKD continuum, including dialysis and kidney transplantation. “This guideline represents a major step forward in how we approach anemia in CKD,” said Dr. Babitt. “It emphasizes a systematic evaluation of anemia and iron deficiency, clearer guidance on when and how to use oral and intravenous iron, and integrates new evidence on emerging therapies while reinforcing the need to avoid overtreatment and to prioritize safety and shared decision-making.” “This guideline reflects a decade of new evidence and the increasing complexity of anemia management in people with chronic kidney disease,” said Dr. Tonelli. “We evaluated a large body of randomized trial data across iron therapies, ESAs, HIF-PHIs, and transfusion strategies, with careful attention to both benefits and harms, to support consistent, evidence-informed anemia care across diverse healthcare systems, resource settings, and patient populations worldwide.” #anemia #CKD

📅 Mark your Calendars! Join GlomCon Arabia’s first session this coming Friday, Jan 9, 2026 Time Zones, link and passcode 👇🏽 Meeting Zoom Link: glomcon.zoom.us/j/2633954930 Meeting ID: 263 395 4930 Passcode: 100499 glomcon.org/arabia-glomcon @poyanmehr @AliMehdiMD @Dr_Ewaida @AyoubIsabelle @MunerMohamed1 @NadaAlachkar @ElfadawyN @AttiehRose @SabineKaram6 @Koubar_Sahar @sam_albadri @GlomerGal @zainabo87 @Nihal_Hamary

💫 2025 was a landmark year for glomerular diseases! Major advances for GN treatment, from IgAN and lupus nephritis to rare diseases like C3G. Can’t wait for what’s coming next! And the eGFR outcomes! Hope these new treatment options are soon available in our countries. #2025 #GlomerularDiseases #IgAN #LN #C3G #GlomLove

Kidney transplant recipients with strong preexisting antibodies face more rejection and graft loss—but with careful immunosuppression, their long-term survival matches others. New 15-year study offers important insights for managing high-risk transplants tinyurl.com/4hu8t3z7

🧵 New #Tweetorial Drop! 🧵 1/ Hey #NephTwitter! 👋 We’re back with a fresh #XTorial from @KIReports, this time diving into: Dapagliflozin in Stage 4 CKD: no diabetes required? 🤔 Let’s unpack what this trial means for your next CKD patient. 💊💭

Presented at #KidneyWk: In the PISCES trial involving participants receiving hemodialysis, fish oil (n−3 fatty acids) was compared with corn-oil placebo. The rate of serious cardiovascular events was lower with daily fish-oil supplementation. Full trial results: nej.md/49zWuqo Editorial: Fish Oil for Patients Receiving Hemodialysis — Red Herring or Great Catch? nej.md/49zWAOM @ASNKidney

📖 A Conservative Dialysis Strategy and Kidney Function Recovery in Dialysis-Requiring Acute Kidney Injury: The LIBERation from AcuTE Dialysis (LIBERATE-D) Randomized Clinical Trial ➡️ Presented today at #KidneyWk ➡️ Free to read online: ja.ma/3X2vrww

Presented today at #KidneyWk: 📚 SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Collaborative Meta-Analysis, from @JAMA_current 🔗Free to read online. ja.ma/3JsDMGL

Come explore a range of important topics in glomerular disease led by renowned glomerular specialists. Don’t miss the opportunity to learn, engage, and connect with experts and colleagues in the field!

Did you miss #GlomCon Hawaii? Don't worry, I took the hit for you and flew to Oahu and stayed in paradise for a week so I could give all of you a summary of what went down. Read all about it...

KDIGO is excited to share the publication of the 2025 Clinical Practice Guideline for the Management of IgA Nephropathy (#IgAN) and IgA Vasculitis (#IgAV), along with the Executive Summary in @Kidney_Int. Read the Guideline in KI: kdigo.co/KDIGO-IgAN-IgA… Download the Executive Summary: kdigo.co/IgAN-IgAV-Guid… Read the News Release: kdigo.co/KDIGO-IgAN-IgA… Co-chaired by Dr. Jürgen Floege (DE) and @BradRovin, this update to the 2021 KDIGO Glomerular Diseases Guideline on IgAN incorporates evidence through August 2024. Given the rapid pace of discovery, KDIGO will continue to update the guideline regularly so clinicians and patients have access to the latest science and recommendations. “This guideline represents a fundamental shift in how we approach IgA nephropathy,” said Dr. Floege. “For the first time, we can target both the immune mechanisms driving IgA injury and the kidney’s maladaptive responses. This dual strategy offers a roadmap to slow progression and extend kidney survival in ways not possible just a few years ago.” “The science is moving faster than ever, and the treatment landscape has changed dramatically,” said Dr. Rovin. “With therapies like targeted-release budesonide, sparsentan, and SGLT2 inhibitors, we can intervene earlier and tailor care. We are moving from a single approach to a toolkit of therapies that can truly change outcomes for people around the world." Download the Guideline: kdigo.co/KDIGO-IgAN-IgA…

🩺 CKRT Core Curriculum 2025 is here! Top nephrology experts unpack real-world pearls in CRRT vs iHD, fluid removal, clearance strategies & hemodynamic stability. Perfect for critical care teams 🚑 🎧 Tune in bit.ly/3DamjQ9

نفخر في مستشفى د. سليمان فقيه في جدة بتحقيق إنجاز استثنائي وغير مسبوق على مستوى العالم، بعد حصولنا على اعتماد 14 مركز تميّز طبي من مؤسسة المراجعة الجراحية Surgical Review Corporation (SRC)، وهو رقم قياسي عالمي لأكبر عدد من مراكز التميّز يتم اعتماده في مستشفى واحد.